Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
S Galmiche, LBL Nguyen, E Tartour… - Clinical Microbiology …, 2022 - Elsevier
Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …
immunocompromised populations, who are at increased risk of severe COVID-19 …
The COVID-19 pandemic and ANCA-associated vasculitis–reports from the EUVAS meeting and EUVAS education forum
A Kronbichler, D Geetha, RM Smith, AC Egan… - Autoimmunity …, 2021 - Elsevier
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic influenced the management
of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. A paucity …
of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. A paucity …
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS
KI Stevens, E Frangou, JI Shin… - Nephrology Dialysis …, 2022 - academic.oup.com
Patients with immune-mediated kidney diseases are at increased risk of severe coronavirus
disease 2019 (COVID-19). The international rollout of COVID-19 vaccines has provided …
disease 2019 (COVID-19). The international rollout of COVID-19 vaccines has provided …
Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients
C Seree-Aphinan, Y Ratanapokasatit… - Frontiers in …, 2023 - frontiersin.org
Background By depleting circulating B lymphocytes, rituximab time-dependently suppresses
coronavirus disease 2019 (COVID-19) vaccines' humoral immunogenicity for a prolonged …
coronavirus disease 2019 (COVID-19) vaccines' humoral immunogenicity for a prolonged …
Predictors of immunogenic response to the BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases treated with …
V Furer, T Eviatar, D Zisman, H Peleg… - Vaccines, 2022 - mdpi.com
Treatment with rituximab (RTX) blunts SARS-CoV-2 vaccination-induced humoral response.
We sought to identify predictors of a positive immunogenic response to the BNT162b2 …
We sought to identify predictors of a positive immunogenic response to the BNT162b2 …
Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases
Many patients with systemic autoimmune rheumatic diseases (SARDs) require
immunosuppression to reduce disease activity, but this also has important possible …
immunosuppression to reduce disease activity, but this also has important possible …
Immunogenicity of SARS-CoV-2 vaccination in rituximab-treated patients: effect of timing and immunologic parameters
D Magliulo, SD Wade, VC Kyttaris - Clinical Immunology, 2022 - Elsevier
Rituximab (RTX), an important therapeutic option for patients with rheumatic diseases, has
been shown to reduce immune responses to various vaccines. We asked whether following …
been shown to reduce immune responses to various vaccines. We asked whether following …
Antibody response to mRNA vaccines against SARS-CoV-2 with chronic kidney disease, hemodialysis, and after kidney transplantation
L Buchwinkler, CA Solagna, J Messner… - Journal of Clinical …, 2021 - mdpi.com
Most trials on mRNA vaccines against SARS-CoV-2 did not include patients with chronic
kidney disease (CKD), hemodialysis (HD) patients, or kidney transplant recipients (KTR) …
kidney disease (CKD), hemodialysis (HD) patients, or kidney transplant recipients (KTR) …
Risk factors associated with poor response to COVID-19 vaccination in kidney transplant recipients
Y Azzi, H Raees, T Wang, L Cleare… - Kidney …, 2021 - kidney-international.org
To the editor: The case fatality ratio of coronavirus disease 2019 (COVID-19) in kidney
transplant recipients is between 10% and 30%, 1, 2 underscoring the importance of …
transplant recipients is between 10% and 30%, 1, 2 underscoring the importance of …
mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?
With the roll-out of coronavirus disease 2019 (COVID-19) vaccines, it has become clear that
vaccinating the majority of the population worldwide will be the most important element to …
vaccinating the majority of the population worldwide will be the most important element to …